无症状高尿酸血症中OMERACT定义痛风超声病变的患病率与鉴别能力:系统评价与荟萃分析
该系统评价与荟萃分析纳入20项研究,评估无症状高尿酸血症人群各部位OMERACT定义痛风超声病变的患病率及其与正常尿酸人群的鉴别能力。结果显示第一跖趾关节双轨征患病率最高(0.31,95%CI 0.20-0.42),股骨髁双轨征和第一跖趾关节痛风石患病率均为0.16,且上述病变的合并比值比最高。结论建议扫描第一跖趾关节和股骨髁的双轨征及第一跖趾关节痛风石。
要点
- 无症状高尿酸血症中第一跖趾关节双轨征患病率最高,为0.31。
- 股骨髁双轨征和第一跖趾关节痛风石患病率均为0.16。
- 第一跖趾关节双轨征、股骨髁双轨征和第一跖趾关节痛风石鉴别正常尿酸人群的比值比最高。
核心结论
- 在无症状高尿酸血症人群中,扫描第一跖趾关节和股骨髁的双轨征以及第一跖趾关节的痛风石具有最高的患病率和鉴别能力。
研究设计与样本
- 系统检索电子数据库、会议摘要和参考文献列表,纳入使用超声成像无症状高尿酸血症人群并报告至少1个OMERACT定义痛风病变的研究,共纳入20项研究。
主要发现
- 扫描最常见的部位是第一跖趾关节(17项研究),报告最常见的病变是双轨征(18项研究)。
- 无症状高尿酸血症中第一跖趾关节双轨征合并患病率为0.31(95%CI 0.20-0.42)。
- 股骨髁双轨征合并患病率为0.16(95%CI 0.08-0.24),第一跖趾关节痛风石合并患病率为0.16(95%CI 0.03-0.29)。
- 无症状高尿酸血症对比正常尿酸人群,第一跖趾关节双轨征合并比值比为6.98(95%CI 3.14-15.57)。
- 股骨髁双轨征合并比值比为13.67(95%CI 5.42-34.49),第一跖趾关节痛风石合并比值比为6.10(95%CI 1.55-24.04)。
关键数值与推荐
- OMERACT定义痛风超声病变包括双轨征、聚集物、痛风石和骨侵蚀。
- 第一跖趾关节双轨征合并患病率0.31(95%CI 0.20-0.42),股骨髁双轨征0.16(95%CI 0.08-0.24),第一跖趾关节痛风石0.16(95%CI 0.03-0.29)。
- 第一跖趾关节双轨征合并比值比6.98(95%CI 3.14-15.57),股骨髁双轨征13.67(95%CI 5.42-34.49),第一跖趾关节痛风石6.10(95%CI 1.55-24.04)。
临床怎么用
- 对无症状高尿酸血症人群,超声扫描可重点关注第一跖趾关节和股骨髁的双轨征以及第一跖趾关节的痛风石。
- 上述部位和病变在无症状高尿酸血症与正常尿酸人群间具有较高的鉴别能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Ultrasound lesions of gout have been described in people with asymptomatic hyperuricemia. However, the anatomical sites and ultrasound lesions most frequently involved in asymptomatic hyperuricemia have not yet been established. This systematic review and meta-analysis aimed to determine the prevalence of the Outcome Measures in Rheumatology (OMERACT) elementary ultrasound lesions of gout (double contour, aggregates, tophus, erosion) at various sites in people with asymptomatic hyperuricemia and to determine which sites and lesions discriminate from people with normouricemia. METHODS: A systematic search of electronic databases, conference abstracts and reference lists was undertaken. Studies were included if they used ultrasound to image people with asymptomatic hyperuricemia and reported ≥1 OMERACT-defined lesion of gout. Meta-analyses were undertaken for the pooled prevalence of site-specific lesions in people with asymptomatic hyperuricemia, and the pooled odds ratios of these lesions compared to people with normouricemia. RESULTS: Twenty studies were included. The most common site scanned was the first metatarsophalangeal joint (1MTP) (n = 17 studies) and the most common lesion reported, the double contour (n = 18). Meta-analyses of pooled prevalence showed 1MTP double contour was the most frequent finding in people with asymptomatic hyperuricemia (0.31, 95% confidence interval (CI) 0.20-0.42), followed by femoral condyle double contour (0.16, 95%CI 0.08-0.24) and 1MTP tophus (0.16, 95%CI 0.03-0.29). The highest pooled odds ratios for asymptomatic hyperuricemia vs. normouricemia were 6.98 (95%CI 3.14-15.57) for 1MTP double contour, 13.67 (95%CI 5.42-34.49) for femoral condyle double contour and 6.10 (95%CI 1.55-24.04) for 1MTP tophus. CONCLUSION: In people with asymptomatic hyperuricemia, scanning of the 1MTP and femoral condyle for double contour, plus the 1MTP for tophus, has the highest prevalence and discrimination compared to those with normouricemia.
引用
- Stewart S, Maxwell H, Dalbeth N, et al. Prevalence and discrimination of OMERACT-defined elementary ultrasound lesions of gout in people with asymptomatic hyperuricaemia: A systematic review and meta-analysis. Semin Arthritis Rheum. 2019. PMID: 30709689. doi:10.1016/j.semarthrit.2019.01.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。